577 filings
Page 3 of 29
8-K
185l8m ezz3
24 Sep 21
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
xf2higybasg6t
10 Aug 21
Altimmune Announces Second Quarter 2021 Financial Results
4:07pm
8-K
r8rsnt h849zdswzgywt
29 Jun 21
Altimmune Announces Update on AdCOVIDTM Phase 1 Clinical Trial
4:30pm
8-K
9ieahm24cpbg2fh
16 Jun 21
Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese Volunteers
7:15am
8-K
scd4 9ipl0
17 May 21
Altimmune Announces First Quarter 2021 Financial Results
7:05am
8-K
pr8v2og79od6pa5rb
1 Apr 21
Other Events
7:30am
8-K
wglelmo
12 Mar 21
Entry into a Material Definitive Agreement
6:08am
8-K
csnaof2rlh95
25 Feb 21
Entry into a Material Definitive Agreement
4:06pm
424B5
pdp20n2k
25 Feb 21
Prospectus supplement for primary offering
8:19am
8-K
bw751le
25 Feb 21
Enrollment in the Phase 1 AdCOVID™ Clinical Trial has Commenced
7:06am
EFFECT
uk68n5q
12 Jan 21
Notice of effectiveness
12:15am
UPLOAD
8y3eh mza
7 Jan 21
Letter from SEC
12:00am
CORRESP
l8qw0tlbb
7 Jan 21
Correspondence with SEC
12:00am
8-K
g6egrb7 cybbf
23 Dec 20
Altimmune Provides an Update on its Investigational New Drug Application
4:20pm